Drug profile · INN
gabapentin
APX-GABAPENTIN
gabapentin (APX-GABAPENTIN) is a voltage-gated calcium channel modulator. Associated with Viatris Pharmaceuticals Co.,. Route of administration: oral. Current US regulatory status: approved.
Drug details — gabapentin
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 2
- Programs
- 13
- Data quality
- 0.89
Quick answer
gabapentin (APX-GABAPENTIN) is a voltage-gated calcium channel modulator. Associated with Viatris Pharmaceuticals Co.,. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated calcium channel modulator
Primary target: Voltage-gated calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is gabapentin?
gabapentin (APX-GABAPENTIN) is a voltage-gated calcium channel modulator. Associated with Viatris Pharmaceuticals Co.,. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for gabapentin?
APX-GABAPENTIN is a marketed brand name for gabapentin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gabapentin?
gabapentin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.